hOGG1 C1245G gene polymorphism associated with prostate cancer: a meta-analysis

被引:5
|
作者
Chen, Yang [1 ,2 ,3 ,4 ]
Li, Jie [1 ,2 ,3 ,4 ]
Li, Tianyu [1 ,2 ,3 ,4 ]
Mo, Zengnan [1 ,2 ,3 ,4 ]
机构
[1] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning 530021, Guangxi Zhuang, Peoples R China
[2] Guangxi Med Univ, Affiliated Hosp 1, Dept Urol & Nephrol, Nanning 530021, Guangxi Zhuang, Peoples R China
[3] Guangxi Med Univ, Guangxi Key Lab Genom & Personalized Med, Nanning 530021, Guangxi Zhuang, Peoples R China
[4] Guangxi Med Univ, Guangxi Collaborat Innovat Ctr Genom & Personaliz, Nanning 530021, Guangxi Zhuang, Peoples R China
关键词
hOGG1; Human oxoguanine glycosylase 1; Polymorphism; Prostate cancer; EXCISION-REPAIR GENES; SER326CYS POLYMORPHISM; BASE-EXCISION; BLADDER-CANCER; RISK; STATISTICS; CHINESE; SUSCEPTIBILITY; XPD; 8-HYDROXYGUANINE;
D O I
10.5301/jbm.5000144
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Prostate cancer (Pca) is one of the most frequently encountered multifactorial malignant diseases worldwide. The human oxoguanine glycosylase 1 (hOGG1) C1245G polymorphism (rs1052133) has been found to be associated with Pca. However, the conclusions have been controversial. Methods: Based on the PubMed, Embase, HuGENet and Chinese National Knowledge Infrastructure (CNKI) databases, this meta-analysis was conducted with 4 models. Eleven qualified studies were included. Results: Although no positive relation was discovered in the pooled analysis, significant associations between rs1052133 and Pca were found in the Asian population (recessive: odds ratio [OR] = 1.580, 95% confidence interval [95% CI], 1.189-2.098; GG vs. GC: OR = 1.504, 95% CI, 1.114-2.030; GG vs. CC: OR = 1.677, 95% CI, 1.201-2.342; allele analysis: OR = 1.249, 95% CI, 1.077-1.449), whites (dominant: OR = 2.138, 95% CI, 1.483-3.083; recessive: OR = 3.143, 95% CI, 1.171-8.437; GG vs. CC: OR = 3.992, 95% CI, 1.891-8.431; allele analysis: OR = 1.947, 95% CI, 1.467-2.586) and mixed populations (recessive: OR = 0.636, 95% CI, 0.484-0.834; GG vs. GC: OR = 0.654, 95% CI, 0.492-0.871; GG vs. CC: OR = 0.624, 95% CI, 0.473-0.823; allele analysis: OR = 0.857, 95% CI, 0.771-0.954). After excluding studies deviating from the Hardy-Weinberg equilibrium, a significant association was also found in the same ethnic groups. In addition, a new positive relation was identified in the "other country" subgroup (with China, South Korea and Australia included) (dominant: OR = 1.622, 95% CI, 1.163-2.261; recessive: OR = 1.773, 95% CI, 1.308-2.404; GG vs. GC: OR = 1.614, 95% CI, 1.169-2.230; GG vs. CC: OR = 2.108, 95% CI, 1.456-3.051; allele analysis: OR = 1.494, 95% CI, 1.235-1.808) and among the Chinese-Korean population. Conclusions: In conclusion, we suggest that the hOGG1 C1245G polymorphism might be potentially associated with Pca risk in different ethnicities and countries, especially among Asians. Further studies are needed to confirm these relations.
引用
收藏
页码:E161 / E168
页数:8
相关论文
共 50 条
  • [41] An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis
    Ji, Changwei
    Liu, Zhao
    Chen, Huimei
    Guo, Hongqian
    Liu, Changjian
    BMC CANCER, 2012, 12
  • [42] Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis
    Effah, Clement Yaw
    Wang, Ling
    Agboyibor, Clement
    Drokow, Emmanuel Kwateng
    Yu, Songcheng
    Wang, Wei
    Wu, Yongjun
    AMERICAN JOURNAL OF MENS HEALTH, 2020, 14 (05)
  • [43] THADA Gene Polymorphism and Prostate Cancer Risk: A Meta-Analysis
    Zhao, Fan
    Xu, Yong
    Yang, Kuo
    Liu, Ming
    Wei, Dong
    Zhang, Yaoguang
    Shi, Xiaohong
    Yang, Fan
    Wang, Xin
    Liang, Siying
    Zhao, Chengxiao
    Chen, Xin
    Sun, Liang
    Zhu, Xiaoquan
    Wang, Nana
    Hui, Juan
    Zhang, Yurong
    Zhu, Ling
    Yang, Yige
    Tang, Lei
    Wang, Jianye
    Yang, Ze
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (03) : 106 - 110
  • [44] The CAG repeat polymorphism of androgen receptor gene and prostate cancer: a meta-analysis
    Mingliang Gu
    Xiaoqun Dong
    Xuezhi Zhang
    Wenquan Niu
    Molecular Biology Reports, 2012, 39 : 2615 - 2624
  • [45] Lack of association between the cyclooxygenase 2-765G>C polymorphism and prostate cancer risk: a meta-analysis
    Feng, Y. -Q.
    Li, Y. U.
    Xiao, W. -D.
    Wang, G. -X.
    Li, Y. O.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 13391 - 13402
  • [46] The hOGG1 Ser326Cys polymorphism is not associated with colorectal cancer risk
    Park, Hye-Won
    Kim, Il-Jin
    Kang, Hio Chung
    Jang, Sang-Geun
    Ahn, Sun-A
    Lee, Jin Soo
    Shin, Hai-Rim
    Park, Jae-Gahb
    JOURNAL OF EPIDEMIOLOGY, 2007, 17 (05) : 156 - 160
  • [47] Correlation analysis of mRNA expression and prognosis of hOGG1 gene polymorphism in patients with non-small cell lung cancer
    Wang, Jing
    Wu, Puzhao
    ONCOLOGY LETTERS, 2019, 18 (03) : 2310 - 2315
  • [48] Ser326Cys polymorphism of hOGG1 gene in postmenopausal breast cancer women from the Lodz region of Poland
    Sobczuk, Anna
    Smolarz, Beata
    Romanowicz-Makowska, Hanna
    Zadrozny, Marek
    Baszczynski, Jakub
    Pertynski, Tomasz
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2009, 8 (02): : 90 - 93
  • [49] The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean population
    Yun, S. J.
    Ha, Y. S.
    Chae, Y.
    Kim, J. S.
    Kim, I. Y.
    Kim, W. J.
    ANNALS OF ONCOLOGY, 2012, 23 (02) : 401 - 405
  • [50] Association between HIF1A rs11549465 polymorphism and risk of prostate cancer: a meta-analysis
    Li, Xiao-Dong
    Zi, Hao
    Fang, Cheng
    Zeng, Xian-Tao
    ONCOTARGET, 2017, 8 (27) : 44910 - 44916